Stay updated with breaking news from ராகவ் ராமிதேவ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Goldman Sachs invests in Aragen Life Sciences (GVK Bio) May 20, 2021 The company has invested more than $3.6 billion in capital since 2006 Goldman Sachs has acquired a significant minority stake in Aragen Life Sciences (Aragen), formerly known as GVK Biosciences, by acquiring shares previously held by ChrysCapital and other existing shareholders. Aragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platforms. Promoted by GV Sanjay Reddy of the Hyderabad based GVK Group in 2001, it has become a specialised contract research organisation. In 2004, DS Brar of Ranbaxy became a co-promoter. While the company did not disclose a deal value, the acquisition of 33 per cent stake is estimated to be about ₹2,400 crore with the company valued at ₹7,300 crore (about a billion dollars). ....
Synopsis Aragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platforms. The company serves a worldwide customer base which spans to the United States, Europe, and Japan. Wall Street behemoth Goldman Sachs has taken a significant minority stake in Aragen Life Sciences, formerly known as GVK Biosciences, a leading contract research organization (CRO), the company announced today. Goldman Sachs, an active investor in India, has acquired shares previously held by ChrysCapital and other existing shareholders. The private equity arm of Goldman Sachs, is all set to acquire about 33% stake in Hyderabad-based GVK Biosciences, making pharma & healthcare as the favourite investment destination amid Covid pandemic, ET reported on Monday. ....
Goldman Sachs investiert in Aragen Life Sciences finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Goldman Sachs invests in Aragen Life Sciences business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.